A large percentage of adults are vitamin D deficient — or close to it — and most have no idea. Estimates suggest roughly 40% of U.S. adults have insufficient levels, based on data from the NIH Office of Dietary Supplements.
In clinic, I see it constantly. A 58-year-old woman came in for a routine visit. No major complaints — just “getting older.” Her 25(OH)D level came back at 14 ng/mL. Three months after supplementation, she was at 48 and told me she felt like herself again. Was that entirely vitamin D? Maybe not. But that pattern shows up often enough that it’s hard to ignore.
We’re not talking about a fringe supplement. Vitamin D is a hormone-like compound affecting bone, immune function, muscle, and likely long-term health. And yet we often wait until there’s a problem to check it.
Quick Take — What Most People Miss
- “Insufficient evidence to screen” does not mean “Vitamin D doesn’t matter”
- You can be significantly deficient with no symptoms at all
- K2 matters — but the evidence is still evolving
- Supplementation should be guided by labs, not guesswork
- Vitamin D deficiency is common and clinically meaningful
- Routine screening is not universally recommended by the USPSTF due to insufficient evidence that it improves outcomes in asymptomatic adults
- Targeted screening is appropriate for at-risk populations: osteoporosis, obesity, limited sun exposure, malabsorption, older age
- Functional medicine and longevity-focused care often screens broadly to establish a baseline and address deficiency early
- Vitamin K2 is often paired with Vitamin D to help regulate calcium distribution — though high-quality outcome data is still evolving
Bottom line: Waiting for deficiency to cause problems is reactive medicine.
Clearing the Record
What People Are Getting Wrong
Misconception 01
“If it mattered, we’d screen everyone.”
That’s not how guideline medicine works. The USPSTF doesn’t say vitamin D isn’t important. It says there isn’t strong enough evidence that screening asymptomatic adults improves long-term outcomes. That’s a gap in data — not a dismissal of importance.
It’s also worth separating two distinct questions: screening for deficiency, and supplementing everyone regardless of status. Those are different questions that are frequently and incorrectly lumped together.
Misconception 02
“Vitamin D is just for bones.”
Outdated. Vitamin D receptors are found in immune cells, brain tissue, the cardiovascular system, and skeletal muscle. This is a system-wide hormone signal — not a single-tissue bone nutrient.
Misconception 03
“If I feel fine, I’m fine.”
Most deficiency is silent. Patients routinely walk around with levels below 20 ng/mL and no obvious symptoms — until problems show up years or decades later. Absence of symptoms is not the same as adequate levels.
The Evidence
What the Science Actually Shows
Bone Health
- Increases intestinal calcium absorption
- Prevents osteomalacia
- Contributes to osteoporosis prevention
- Deficiency treatment supported by the Endocrine Society
Immune Function
- Regulates innate and adaptive immune responses
- Meta-analysis data shows modest reduction in respiratory infections
- ~2% absolute risk reduction (Martineau et al., BMJ 2017)
Muscle Function
- Low levels linked to weakness and fatigue
- Associated with increased fall risk in older adults
- Especially relevant for physical performance
Cardiometabolic Health
- Observational links to hypertension, diabetes, and CVD
- Interventional data is mixed
- Deficiency is consistently unfavorable across studies
“Treating deficiency is strongly supported. Screening everyone for optimization is still being studied. Those are separate questions — and conflating them is how nuance gets lost.”
— Chad Street, FNP-BCClinical Reality
What I See in Practice
Vitamin D deficiency is everywhere. The contributing factors are largely lifestyle and physiology: indoor work and leisure, sunscreen use (important, but it reduces synthesis), higher body fat which sequesters vitamin D in adipose tissue, aging skin that produces less, and geographic reality — in Tennessee and most of the continental U.S., UVB exposure is insufficient during winter months to produce meaningful vitamin D at all.
I routinely see levels below 20 ng/mL in asymptomatic patients. Occasionally below 10 ng/mL in patients who have never been tested. After correction, some report improved energy and less discomfort. Others notice nothing measurable.
That’s real medicine — variable response, but consistent physiology. Whether a patient notices a difference or not, restoring adequate levels matters for the underlying biology.
The Missing Piece
Why Vitamin K2 Matters — And What We Actually Know
Vitamin D increases calcium absorption. It doesn’t control where that calcium goes.
This is the core of the D3/K2 argument: without K2, the calcium that vitamin D pulls into your bloodstream has to go somewhere. Ideally, it goes into bone. But without the K2-dependent proteins that direct it there, it can deposit in soft tissues and arterial walls — exactly where you don’t want it.
What K2 (MK-7) Actually Does
MK-7 is the most bioavailable form of K2, with a longer half-life than MK-4. It activates two key proteins:
Osteocalcin — a protein in bone that, when activated by K2, helps bind calcium into the bone matrix. Without adequate K2, osteocalcin remains undercarboxylated and less effective at mineralization.
Matrix Gla protein (MGP) — one of the most potent inhibitors of vascular calcification known. K2 activates MGP, which prevents calcium from depositing in arterial walls. Studies in chronic kidney disease patients have shown that inactive (undercarboxylated) MGP is directly associated with arterial stiffness and calcification.
Mechanistic data supporting K2’s role in calcium direction
Observational data linking K2 intake to vascular and bone outcomes
RCT data on healthy adults — most trials involve higher-risk populations
A 2023 meta-analysis (Li et al., Frontiers in Nutrition) suggests slowing of vascular calcification with K2 supplementation, but most trials involve higher-risk populations such as CKD patients, limiting how broadly we can apply the findings.
The honest bottom line: Pairing D3 + K2 is physiologically logical and very low-risk — but it is not yet backed by definitive outcome trials in healthy adults. The mechanism is compelling. The long-term human trial data is still catching up.
Without Supplements
How to Get Vitamin D Naturally
Sunlight (Primary Source)
UVB radiation converts a cholesterol precursor in the skin into vitamin D3. Production depends heavily on time of day (UVB angle), latitude, skin tone, sunscreen use, and age. In Middle Tennessee and similar latitudes, effective UVB is essentially unavailable from November through February — meaning even daily outdoor sun exposure during winter months will not produce meaningful vitamin D.
Food Sources (Limited)
Fatty fish (salmon, mackerel, sardines), egg yolks, and fortified foods (milk, orange juice, cereals) contain some vitamin D — but the amounts are modest. Diet alone rarely corrects deficiency, and food sources cannot reliably maintain optimal levels.
Optimizing Further
The Longevity Angle
| Approach | Target Range | Status |
|---|---|---|
| Standard guidelines (Endocrine Society) | 30–50 ng/mL | Well supported |
| Longevity-focused / functional medicine | 50–80 ng/mL | Under study |
| Toxicity risk begins | > 100 ng/mL | Avoid |
Correcting frank deficiency is not controversial — there is strong consensus on that. Pushing levels higher for optimization purposes is still being studied. “Adequate” and “optimal” may not be the same target, but what “optimal” actually looks like in long-term outcome data hasn’t been fully defined.
From a practical standpoint: get your level, correct it if it’s low, maintain it in the 40–60 ng/mL range, and recheck periodically. That’s a defensible, evidence-anchored approach.
Know the Limits
A Note on Safety
Vitamin D Toxicity Is Rare — But Real
Vitamin D is fat-soluble, meaning it accumulates in the body over time rather than being excreted. Toxicity typically occurs with chronic high dosing above 10,000 IU/day and leads to hypercalcemia (elevated blood calcium), which can cause kidney stones, calcification of soft tissues, and cardiac arrhythmias.
- Maintenance dosing of 1,000–2,000 IU/day is generally safe for most adults
- Higher doses (4,000–10,000 IU/day) should be lab-guided and monitored
- Recheck levels 8–12 weeks after starting or changing dose
Practical Steps
What to Do About It
Get a Baseline
Ask your provider for a 25-hydroxyvitamin D [25(OH)D] level. This is the correct test — not the activated form (1,25-dihydroxyvitamin D), which does not reflect stored status. Out-of-pocket cost is typically low, and it’s frequently covered by insurance.
Know Your Range
Interpret your result with context:
| Level | Interpretation |
|---|---|
| < 20 ng/mL | Deficient |
| 20–29 ng/mL | Insufficient |
| 30–50 ng/mL | Adequate |
| 50–80 ng/mL | Longevity target range |
Supplement Intentionally
Vitamin D3 (cholecalciferol) is preferred over D2. Take it with a fat-containing meal to improve absorption.
Typical dosing:
- Maintenance: 1,000–2,000 IU daily
- Deficiency correction: higher doses, lab-guided
Recheck After 8–12 Weeks
Retest your 25(OH)D level 8–12 weeks after starting or adjusting supplementation. Levels move slowly — don’t adjust dose without a follow-up lab. Once stable, annual rechecks are appropriate for most people.
The Takeaway
Bottom Line
Vitamin D deficiency is common, easy to miss, and easy to fix. The debate isn’t whether it matters — it does. The real question is whether you wait for problems to develop, or check and address it early.
Getting a baseline level is a low-cost, low-risk decision that gives you useful, actionable information. Pairing D3 with K2 in the MK-7 form is physiologically sound and carries minimal downside. Supplement with intention, dose by labs, and recheck.
That’s not optimization for its own sake — that’s just doing what the evidence supports before the problem announces itself.
Sources
- U.S. Preventive Services Task Force. Vitamin D Deficiency Screening Recommendation Statement. JAMA, 2021.
- Endocrine Society. Vitamin D Deficiency Clinical Practice Guideline.
- National Institutes of Health Office of Dietary Supplements. Vitamin D Fact Sheet.
- National Institutes of Health Office of Dietary Supplements. Vitamin K Fact Sheet.
- Martineau AR, et al. Vitamin D supplementation to prevent acute respiratory tract infections. BMJ, 2017.
- Li T, et al. Effect of vitamin K2 on vascular calcification. Frontiers in Nutrition, 2023.
- Holick MF. Vitamin D deficiency. New England Journal of Medicine, 2007.